MwanzoNVS • NYSE
Novartis AG
$ 116.19
27 Sep, 11:31:01 GMT -4 · USD · NYSE · Kanusho
Nembo ya GLeafInaongoza katika utunzaji wa mazingiraHisa zinazouzwa MarekaniMakao yake makuu ni CH
Bei iliyotangulia
$ 115.61
Bei za siku
$ 115.79 - $ 116.39
Bei za mwaka
$ 92.19 - $ 120.92
Thamani ya kampuni katika soko
253.11B USD
Wastani wa hisa zilizouzwa
1.01M
Alama ya CDP ya Tabia Nchi
A
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
12.87B9.60%
Matumizi ya uendeshaji wa biashara
5.40B-1.58%
Mapato halisi
3.25B40.16%
Kiwango cha faida halisi
25.2227.89%
Mapato kwa kila hisa
1.977.65%
EBITDA
5.36B30.39%
Asilimia ya kodi ya mapato
15.49%
Jumla ya mali
Jumla ya dhima
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
8.43B-23.85%
Jumla ya mali
97.50B-12.14%
Jumla ya dhima
55.60B-5.83%
Jumla ya hisa
41.90B
hisa zilizosalia
2.02B
Uwiano wa bei na thamani
5.61
Faida inayotokana na mali
11.21%
Faida inayotokana mtaji
15.59%
Mabadiliko halisi ya pesa taslimu
(USD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
3.25B40.16%
Pesa kutokana na shughuli
4.88B36.33%
Pesa kutokana na uwekezaji
-3.21B-204.56%
Pesa kutokana na ufadhili
-3.20B12.02%
Mabadiliko halisi ya pesa taslimu
-1.57B-40.45%
Mtiririko huru wa pesa
1.80B1,106.13%
Kuhusu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes”. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
29 Feb 1996
Wafanyakazi
76,057
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu